Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
View:
• age 18 - 65 years old;
• Diagnosis of F20, F25 or F21 according to ICD-10;
• Signed informed consent form.
Locations
Other Locations
Lithuania
Jonas Montvidas
RECRUITING
Kaunas
Lithuanian University of Health Sciences Hospital Kaunas Clinics
RECRUITING
Kaunas
Contact Information
Primary
Jonas Montvidas, MD
jonas.montvidas@lsmu.lt
+37066240919
Backup
Algirdas Musneckis, MD
algirdas.musneckis@kaunoklinikos.lt
+37061378748
Time Frame
Start Date: 2023-12-11
Estimated Completion Date: 2026-12-11
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: Lithuanian University of Health Sciences